Goteborg

• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 5 Locally Advanced or Metastatic Cholangiocarcinoma
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending
  2023-504654-35-00 4 Graves Ofthalmopathy
• Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Pending
  2024-510617-15-00 5 Non-metastatic resectable pancreatic cancer
• Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending
  2024-511054-50-00 10 HIV-1 Infection
• GLUTAMICS III Pending
  2024-513575-40-01 5 Acute kidney injury and heart failure after coronary artery bypass sur
• K-SAB trial Pending
  2024-515250-25-00 3 Advanced KRASG12C-mutated non-small cell lung cancer subjects who prev
• The Swedish Nationwide Clinical Trial to Facilitate Patient Access to Targeted Cancer Treatment based on Biomarker Profiling (FOCU.SE) Pending
  2024-516003-16-00 4 Advanced Cancer
• SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending
  2024-516228-33-00 6 Type 2 Diabetes
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 Rheumatoid Arthritis
• Immediate insertion of intrauterine contraception after medical abortion Pending
  2024-517082-16-01 5 Post medical abortion contraception
• Study of Intravenous ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibros … Pending
  2024-518013-25-00 4 Idiopathic Pulmonary Fibrosis
• Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending
  2024-518706-41-01 5 Cardiovascular disease
• ProFertil Pending
  2024-518977-32-00 5 Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and non-Hodgkin) ans
• A randomized controlled trial of the effect of anesthetic dose during electroconvulsive therapy for major depression Pending
  2024-519407-99-00 6 Major depressive disorder
• Neoadjuvant pembrolizumab in patients with stage IIb/c melanoma, a phase II double-blind placebo-controlled randomized trial NEOPRIME Pending
  2024-519594-19-00 4 Stage IIb/c melanoma
• An interventional, Open-label Study to Evaluate the effect of lebrikizumab on eczema and Skin Barrier Function parameters in lesional and no … Pending
  2024-519811-32-00 6 Atopic dermatitis
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Pending
  2025-520565-51-00 5 small cell lung cancer
• Personalizing chemotherapy selection after surgery for patients with stage III colorectal cancer using a blood test Pending
  2025-521045-24-00 5 Stage III colorectal cancer
• Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control Trial Pending
  2025-521795-58-00 11 Abdominal aortic aneurysm
• The REFINE study Pending
  2025-522133-66-00 5 Autoimmune Premature Ovarian Insufficiency
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• Patient Evaluation of OraFID, a New Medicine Dispenser and App for Flexilev minitablets Pending
  2025-524296-23-01 6 Parkinsons Disease

Showing 1–24 of 303 trials